Search results
Results From The WOW.Com Content Network
Glaxo's $3 billion settlement included the largest civil False Claims Act settlement on record, [1] and Pfizer’s $2.3 billion ($3.5 billion in 2022) settlement including a record-breaking $1.3 billion criminal fine. [2] Legal claims against the pharmaceutical industry have varied widely over the past two decades, including Medicare and ...
The following is a list of the 21 largest civil settlements, reached between the United States Department of Justice and pharmaceutical companies from 2001 to 2017, ordered by the size of the total civil settlement. Some of these matters also resolved criminal fines and penalties, listed in parentheses, but these amounts are not considered when ...
Pfizer: Off-label promotion of Bextra, Geodon, Zyvox and Lyrica, September 2009. In what was the largest pharmaceutical settlement in U.S. history at the time, Pfizer reached a $2.3 billion settlement with the Department of Justice to resolve criminal charges and civil claims under the False Claims Act.
The buyout talks involving Acadia underscore the renewed interest by private equity firms in the sector, following U.S. legislative reforms that expanded insurance coverage for behavioral health ...
Total equity. US$699.14 million (2019) Number of employees. 570 (June 30, 2020) Website. acadia .com. Footnotes / references. [1] Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California.
Microsoft Corp. has agreed to pay $14.4 million to settle allegations that the global software giant retaliated and discriminated against employees who took protected leave, including parental and ...
The Acadians ( French: Acadiens [akadjɛ̃], Acadian French: [akad͡zjɛ̃]) are an ethnic group descended from the French who settled in the New France colony of Acadia during the 17th and 18th centuries. Today, most descendants of Acadians live in the Northern American region of Acadia, where descendants of Acadians who escaped the Expulsion ...
Minnesotans with diabetes will pay no more than $35 monthly for Eli Lilly's brand-name insulin products, at least for the next five years, under a settlement announced Wednesday by state Attorney ...